NASDAQ:SOLY

Soliton (SOLY) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$22.58
$22.58
50-Day Range
$20.10
$22.58
52-Week Range
$7.40
$22.60
Volume
N/A
Average Volume
347,827 shs
Market Capitalization
$487.66 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
SOLY stock logo

About Soliton Stock (NASDAQ:SOLY)

Soliton, Inc. is a medical development company, which engages in the development of healthcare technological devices for medical and cosmetic treatments. Its technology platform include Rapid Acoustic Pulse, a device uses rapid pulses of designed acoustic shockwaves to disrupt cellular structures in the dermal and subdermal tissue. The firm is also in the pre-revenue stage with its first products being developed for the removal of tattoos and the reduction of cellulite. The company was founded by Walter V. Klemp and Christopher Capelli on March 27, 2012 and is headquartered in Houston, TX.

SOLY Stock News Headlines

Elon Musk’s Controversial New Project: “Apollo”
Have you seen this footage outside the headquarters of Elon Musk's "Project Apollo?" Big Tech and the mainstream media have called this project "controversial"...
General Maximum - Seeking Alpha
Elon Musk’s Controversial New Project: “Apollo”
Have you seen this footage outside the headquarters of Elon Musk's "Project Apollo?" Big Tech and the mainstream media have called this project "controversial"...
Allergan Aesthetics Completes Acquisition of Soliton
See More Headlines
Receive SOLY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Soliton and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/12/2021
Today
4/24/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & Medical Instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:SOLY
Fax
N/A
Employees
14
Year Founded
N/A

Profitability

Net Income
$-14,540,000.00
Pretax Margin
-4,831.89%

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$1.46 per share

Miscellaneous

Free Float
19,005,000
Market Cap
$487.66 million
Optionable
Not Optionable
Beta
0.19
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Bradley A. Hauser
    President, Chief Executive Officer & Director
  • Joseph D. Tanner
    Chief Operating Officer
  • Lori Bisson
    Chief Financial Officer, Secretary & Executive VP
  • Christopher Capelli
    Vice Chairman & Chief Science Officer
  • Mary Stoll
    Senior Director-Clinical Development

SOLY Stock Analysis - Frequently Asked Questions

How were Soliton's earnings last quarter?

Soliton, Inc. (NASDAQ:SOLY) issued its quarterly earnings results on Thursday, August, 12th. The company reported ($0.37) EPS for the quarter, missing the consensus estimate of ($0.30) by $0.07.

What other stocks do shareholders of Soliton own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Soliton investors own include Cronos Group (CRON), NVIDIA (NVDA), Advanced Micro Devices (AMD), Tesla (TSLA), AbbVie (ABBV), Micron Technology (MU), Block (SQ) and Verizon Communications (VZ).

This page (NASDAQ:SOLY) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners